Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SIBP MMR vaccine in African children
NCT06399003Phase 3Completed
- Sponsor
- Shanghai Institute of Biological Products
- Start
- Jun 2024
- Primary completion
- Sep 2024
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of SIBP MMR Vaccine in measles, mumps, rubella, sponsored by Shanghai Institute of Biological Products. Started Jun 2024; status: completed.
02
Drugs
SIBP MMR Vaccine
03
Conditions
measlesmumpsrubella
Beyond the preview
Go deeper on NCT06399003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06399003.